Clonal haematopoiesis of indeterminate potential and mortality in coronary artery disease.

Eur Heart J · 2026 · PMC12831187 · PMID 40900105

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Clinically, TET2 CHIP carriers showed a trend toward higher cardiovascular risk, reinforcing the role of TET2 CHIP in plaque vulnerability and adverse outcomes.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Given limited power, CALR [HR 4.09 (95% CI 0.68–24.56)] and ZRSR2 [HR 1.91 (95% CI 0.92–3.96)] did not reach statistical significance at VAF ≥2%.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.